Biological imaging for the diagnosis of inflammatory conditions

BioDrugs

Volumn 16, Issue 4, 2002, Pages 241-259

  Signore, Alberto ^a,d   Annovazzi, Alessio ^a   Corsetti, Federica ^a   Capriotti, Gabriela ^a   Chianelli, Marco ^b   De Winter, Frederic ^c   Scopinaro, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; AVIDIN; BIOTIN; CEFTIZOXIME; CHEMOTACTIC PEPTIDE; CIPROFLOXACIN; DEFENSIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUCONAZOLE; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; INDIUM 111; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE INHIBITOR; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; OKT 3; PENTETREOTIDE; PENTETREOTIDE IN 111; POLYCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; RP128; SUBSTANCE P; THROMBOCYTE FACTOR 4; TUFTSIN; UNINDEXED DRUG;

APOPTOSIS; CELL ACTIVATION; CELL INFILTRATION; CHRONIC INFLAMMATION; DIAGNOSTIC VALUE; EDEMA; ENDOTHELIUM CELL; HUMAN; IMAGING; INFLAMMATORY DISEASE; ISOTOPE LABELING; LYMPHOCYTE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0036385845     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200216040-00002     Document Type: Review

References (182)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54
2. Procaccini E, Chianelli M, Pantano P, et al. Imaging of autoimmune disease. Q J Nucl Med 1999; 43: 100-12
3. Welling MM, Paulusma-Annema A, Balter HS, et al. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000; 27: 292-301
4. Corstens FHM. Van der Meer JWM. Nuclear medicine's role in infection and inflammation. Lancet 1999; 354: 765-70
5. Chianelli M, Mather SJ, Martin Comin J, et al. Radiopharmaceutical for the study of inflammatory processes: a review. Nucl Med Commun 1997; 18: 437-55
6. Okarvi SM. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview. Nucl Med Commun 1999; 20: 1093-112
7. Boerman OC, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med 2000; 30:195-208
8. Signore A, Annovazzi A, Chianelli M, et al. Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 2001; 28: 1555-65
9. Behran J. MR imaging of soft tissue infection. Magn Reson Imaging Clin N Am 1995; 3: 743-51
10. Lindner JR. Assessment of inflammation with contrast ultrasound. Prog Cardiovasc Dis 2001; 44: 111-20
11. Vinjamuri S, Hall AV, Solanki KK, et al. Comparison of 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347: 233-5
12. Gomes Barreto V, Iglesias F, Roca M, et al. Labelling of ceftizoxime with 99mTc. Rev Esp Med Nucl 2000; 19: 479-83
13. Nibbering PH, Welling MM, Van den Broek PJ, et al. Radiolabelled antimicrobial peptides for imaging of infections: a review. Nucl Med Commun 1998; 19: 1117-21
14. Welling MM, Lupetti A, Balter HS, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001; 42: 788-94
15. Rubin RH, Young LS, Hansen WP, et al. Specific and non-specific imaging of localized Fisher immunotype I Pseudomonas aeruginosa infection with radiolabelled monoclonal antibody. J Nucl Med 1988; 29: 651-6
16. De Winter F, Van de Wiele C, Dumont F, et al. Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection, Eur J Nucl Med 2001 May; 28: 570-4
17. Yapar Z, Kibar M, Yapar AF, et al. The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med 2001; 28: 822-30
18. Valtonen V, Karppinen L, Kariniemi AL. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Scand J Infect Dis Suppl 1989; 60: 79-83
19. Poulain D, Deveaux M, Cailliez JC, et al. Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: experimental study in the guinea pig. Int J Rad Appl Instrum B 1991: 18: 677-86
20. Lupetti A, Welling M, Mazzi U, et al. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med 2002; 29: 674-9
21. Brust P, Haubner R, Friedrich A, et al. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur J Nucl Med 2001; 28: 721-9
22. Bennett JJ, Tjuvajev J, Johnson P, et al. Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat Med 2001; 7: 859-63
23. Chapman PT, Jamar F, Harrison AA, et al. Noninvasive imaging of E-selectin expression by activated endothelium in urate crystal-induced arthritis. Arthritis Rheum 1994; 37: 1752-6
24. Chapman PT, Jamar F, Keelan ETM, et al. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996; 39: 1371-5
25. Gratz S, Behe M, Boerman OC, et al. (99m)Tc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model. Nucl Med Commun 2001; 22: 1003-13
26. Weiner RE, Sasso DE, Gionfriddo MA, et al. Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 1998; 39: 723-8
27. Weiner RE, Sasso DE, Gionfriddo MA, et al. Early detection of oleic acid-induced lung injury in rats using (111)In-labeled anti-rat intercellular adhesion molecule-1. J Nucl Med 2001; 42: 1109-15
28. Fischman AJ, Rubin RH, Khaw BA, et al. Detection of acute inflammation with 111In-labelled nonspecific polyclonal IgG. Semin Nucl Med 1988; 18: 335-44
29. Buscombe JR, Lui D, Ensing G, et al. 99mTc-human immunoglobulin (HIG): first results of a new agent for the localization of infection and inflammation. Eur J Nucl Med 1990; 16: 649-55
30. Claessens RA, Boerman OC, Koenders EB, et al. Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations. Eur J Nucl Med 1996; 23: 414-21
31. Morrel EM, Tompkins RG, Fischmann AJ, et al. Autoradiographic method for quantitation of radiolabelled proteins in tissues using indium-111. J Nucl Med 1989; 30: 1538-45
32. Fischman AJ, Rubin RH, White JA, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990: 31: 1199-205
33. de Bois MH, Welling M, Verwey CL, et al. 99Tcm-HIG accumulates in the synovial tissue of rats with adjuvant arthritis by binding to extracellular matrix proteins. Nucl Med Commun 1996; 17: 54-9
34. Calame W, Welling M, Feitsma HI, et al. Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammation. Eur J Nucl Med 1995; 22: 638-44
35. Buscombe JR, Oyen WJ, Corstens FH, et al. A comparison of 111In-HIG scintigraphy and chest radiology in the identification of pulmonary infection in patients with HIV infection. Nucl Med Commun 1995; 16: 327-35
36. Oyen WJG, Van Horn JR, Claessens RAMJ, et al. Diagnosis of bone, joint and joint prosthesis infections with indium-111 labelled human immunoglobulin G scintigraphy. Radiology 1992; 82: 195-9
37. Buscombe JR, Miller RF, Lui D, et al. Combined 67Ga citrate and 99Tcm-human immunoglobulin imaging in human immunodeficiency virus-positive patients with fever of undetermined origin. Nucl Med Commun 1991; 12: 583-92
38. Liberatore M, Clemente M, Iurilli AP, et al. Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human nonspecific immunoglobulins, leukocytes and albumin nanocolloids. Eur J Nucl Med 1992; 19: 853-7
39. Rusckowski M, Fritz B, Hnatowich D. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992; 33: 1810-5
40. Samuel A, Paganelli G, Chiesa R, et al. Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy. J Nucl Med 1996; 37: 55-61
41. Lazzeri E, Manca M, Molea N, et al. Clinical validation of the avidin-111In biotin approach for imaging infection/inflammation in orthopaedic patients. Eur J Nucl Med 1999; 26: 606-14
42. De Schrijver M, Streule K, Senekowitsch R, et al. Scintigraphy of inflammation with nanometer-sized colloidal tracers. Nucl Med Commun 1987; 8: 895-908
43. Sohn MH, Jones BJ, Whiting Jr JH, et al. Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice. J Nucl Med 1993; 34: 2135-43
44. Roitt I. Essential immunology. 8th ed. Oxford: Blackwell Scientific, 1994
45. Van Leeuwen-Stok EA, Jonkhoff AR, Visser-Platier AW, et al. Cell cycle dependency of 67-gallium uptake and cytotoxicity in human cell lines of hematological malignancies. Leuk Lymphoma 1998; 31: 533-44
46. Halpern S, Hagan P. Gallium-67-citrate imaging in neoplastic and inflammatory diseases. In: Freeman LM, Weissman H, editors. Nuclear medicine annual. New York: Raven Press, 1980: 219-65
47. Kao C, Wang S, Liao S, et al. Usefulness of gallium-67-citrate scans in patients with acute disseminated tuberculosis and comparison with chest x-rays. J Nucl Med 1993; 34: 1918-21
48. Sulavik SB, Spencer RP, Palestro CJ, et al. Specificity and sensitivity of distinctive chest radiographic and/or 67-Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993; 103: 403-9
49. Lin WY, Cheng KY, Wang SJ. Gallium-67 scintigraphy in lupus nephritis. Clin Nucl Med 1998; 23: 517-20
50. Lin WY, Lan JL, Wang SJ. Gallium-67 scintigraphy to predict response to therapy in active lupus nephritis. J Nucl Med 1998; 39: 2137-41
51. Hadjipavlou AG, Cesani-Vazquez F, Villaneuva-Meyer J, et al. The effectiveness of gallium citrate Ga 67 radionuclide imaging in vertebral osteomyelitis revisited. Am J Orthop 1998; 27: 179-83
52. Turpin S, Lambert R. Role of scintigraphy in musculoskeletal and spinal infections. Radiol Clin North Am 2001; 39: 169-89
53. Wassie E, Buscombe J, Miller R, et al. 67-Ga scintigraphy in HIV antibody positive patients: a review of its clinical usefulness. Br J Radiol 1994; 67: 349-52
54. Peters AM. Nuclear medicine imaging in fever of unknown origin. Q J Nucl Med 1999; 43: 61-73
55. Zakhireh B, Thakur ML, Malech HL, et al. Indium-111-labeled polymorphonuclear leukocytes: viability, random migration, chemotaxis, bactericidal capacity and ultrastructure. J Nucl Med 1979; 20: 741-7
56. Thakur M, Segal A, Louis L, et al. Indium-111-labelled cellular blood components: mechanism of labelling and intracellular location in human neutrophils. J Nucl Med 1977; 18: 1022-6
57. Roca M, Martin-Comin J, Becker W, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med 1998; 25: 797-9
58. Plucher MR, Blower PJ. Labelling of leukocytes with colloidal technetium-99m-SnF2: an investigation of the labelling process by autoradiography. J Nucl Med 1995; 22: 101-7
59. Silvester D, Waters S. Dosimetry of radiolabelled white blood cells. Int J Nucl Biol 1983; 10: 141-4
60. Thakur M, McAfee J. The significance of chromosomal aberrations in indium-111-labelled lymphocytes. J Nucl Med 1984; 25: 922-7
61. Becker W, Schomann E, Fischbach W, et al. Comparison of Tc-99m-HMPAO and In-111-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988; 9: 435-47
62. Furno A, Gallo R, Gambetti M, et al. Radiation induced chromosomal damage to lymphocytes in usual 99m-Tc-HMPAO leukocytes preparations. In: Martin-Comin J, Thakur ML, Piera C, et al., editors. Radiolabelled blood elements: recent advances in techniques and applications. New York: Plenum Press, 1994: 177-82
63. de Labriolle-Vaylet C, Colas-Linhart N, Sala-Trepat M, et al. Biological consequences of the heterogeneous irradiation of lymphocytes during technetium-99m hexamethylpropylene amine oxime white blood cell labelling. Eur J Nucl Med 1998; 25: 1423-8
64. Peters AM. The utility of 99m-Tc-HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110-27
65. Liberatore M, Iurilli AP, Ponzo F, et al. Clinical usefulness of technetium-99m-HMPAO-labeled leukocyte scan in prosthetic vascular graft infection. J Nucl Med 1998; 39: 875-9
66. Larikka MJ, Ahonen AK, Junila JA, et al. Extended combined 99mTc-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections. Eur J Nucl Med 2001; 28: 288-93
67. Krznaric E, Roo MD, Verbruggen A, et al. Chronic osteomyelitis: diagnosis with technetium-99m-d, l-hexamethylpropylene amine oxime labelled leucocytes. Eur J Nucl Med 1996; 23: 792-7
68. Liberatore M, Fiore V, D'Agostini A, et al. Sternal wound infection revisited. Eur J Nucl Med 2000; 27: 660-7
69. Martin-Comin J, Prats E. Clinical applications of radiolabeled blood elements in inflammatory bowel disease. Q J Nucl Med 1999; 43: 74-82
70. Medina M, Viglietti AL, Gozzoli L, et al. In-111 labelled white blood cell scintigraphy in cranial and spinal septic lesions. Eur J Nucl Med 2000; 27: 1473-80
71. Puncher MR, Blower PJ. Labelling of leucocytes with colloidal technetium-99m-SnF2: an investigation of the labelling process by antoradiography. Eur J Nucl Med 1995; 22: 101-7
72. Boerman OC, Rennen H, Oyen WJ, et al. Radiopharmaceuticals to image infection and inflammation. Semin Nucl Med 2001; 31: 286-95
73. Devillers A, Garin E, Polard JL, et al. Comparison of Tc-99m-labelled anti-leukocyte fragment Fab' and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 2000; 21: 747-53
74. Bosslet K, Auerbach B, Hoffken H, et al. Frequency and relevance of the human anti-mouse immunoglobulin (HAMA) response in immunoscintigraphy. Nucl Med 1989; 28: 149-59
75. Becker W, Goldenberg GM, Wolf F. The use of monoclonal antibodies and antibodies fragments in the imaging of infectious lesions. Semin Nucl Med 1994; 24: 1-13
76. Mahida YR, Perkins AC, Frier M, et al. Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun 1992; 13: 330-5
77. Peltier P, Potel G, Lovat E, et al. Detection of lung and bone infection with anti-granulocyte monoclonal antibody BW 250/183 radiolabelled with 99Tcm. Nucl Med Commun 1993; 14: 766-74
78. Dominguez-Gadea L, Martin-Curto LM, de la Calle H, et al. Diabetic foot infections: scintigraphic evaluation with 99Tcm-labelled anti-granulocyte antibodies. Nucl Med Commun 1993; 14: 212-8
79. Rypins EB, Kipper SL, Weiland F, et al. 99m Tc anti-CD 15 monoclonal antibody (LeuTech) imaging improves diagnostic accuracy and clinical management in patients with equivocal presentation of appendicitis. Ann Surg 2002; 235: 232-9
80. Gratz S, Behr T, Herrmann A, et al. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection. Eur J Nucl Med 1998; 25: 386-93
81. Wu AM, Yazaki PJ. Designer genes: recombinant antibody fragments for biological imaging. Q J Nucl Med 1999; 43: 268-83
82. Becker W, Bair J, Repp R, et al. Disclosure of soft tissue infections and osteomyelitis with a new technetium labelled antigranulocyte monoclonal antibody fragment. J Nucl Med 1994; 35: 1436-43
83. Harwood SJ, Valdivia S, Hung GL, et al. Use of sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis 1999; 28: 1200-5
84. Gratz S, Raddatz D, Hagenah G, et al. 99mTc-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol 2000; 75: 75-84
85. Barron B, Hanna C, Passalaqua AM, et al. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab' fragment. LeukoScan Appendicitis Clinical Trial Group. Surgery 1999; 125: 288-96
86. Signore A, Procaccini E, Annovazzi A, et al. The developing role of cytokines for imaging inflammation and infection. Cytokine 2000; 12: 1445-54
87. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52
88. Lowenthal JW, MacDonald HR. Binding and internalization of interleukin-1 by T-cells. J Exp Med 1986; 164: 1060-74
89. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study. Eur J Nucl Med 1998; 25: 347-52
90. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Preferential localization of systemically administered radiolabeled interleukin-1alpha in experimental inflammation in mice by binding to the type II receptor. J Clin Invest 1997; 100: 2970-6
91. Granowitz EV, Porat R, Mier JW, et al. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992; 4: 353-60
92. Van der Laken CJ, Boerman OC, et al. Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection. Eur J Nucl Med 1996; 23: 1531-5
93. Barrera P, Van der Laken CJ, Boerman OC, et al. Radiolabeled interleukin-1 receptor antagonist for the detection of synovitis in patients with rheumatoid arthritis. Rheumatology 2000; 39: 870-4
94. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Targeting inflammation with radiolabeled interleukin-1 and other cytokines in various mouse models [abstract]. Nucl Med Commun 1997; 18: 478
95. Ben-Baruch A, Michiel DF, Oppenheim JJ. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 1995; 270: 11703-16
96. Lee J, Horuk R, Rice GC, et al. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267: 16283-7
97. Yoshimura T, Matsushima K, Oppenheim JJ, et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (IL-1). J Immunol 1987; 139: 788-93
98. Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427-32
99. Izzo RS, Witkon K, Chen AI, et al. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 1447-52
100. Endo H, Akahoshi T, Takagishi K, et al. Elevation of interleukin-8 (IL8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991; 10: 245-52
101. Van der Laken CJ, Boerman OC, Oyen WJG, et al. The kinetics of radiolabeled interleukin-8 in infection and sterile inflammation. Nucl Med Commun 1998; 19: 271-81
102. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours. J Nucl Med 2000; 41: 463-9
103. Rennen HJJM, Boerman OC, Oyen WJG, et al. Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8. J Nucl Med 2001; 42: 117-23
104. Rennen HJ, Boerman OC, Koenders EB, et al. Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction. Nucl Med Biol 2000; 27: 599-604
105. Gratz S, Rennen HJ, Boerman OC, et al. Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. J Nucl Med 2001; 42: 917-23
106. Gratz S, Rennen HJ, Boerman OC, et al. (99m)Tc-interleukin-8 for imaging acute osteomyelitis. J Nucl Med 2001; 42: 1257-64
107. Laterveer L, Lindley IJD, Heemskerk DPPM, et al. Rapid mobilization of hematopoietic progenitor cells in Rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996; 87: 781-8
108. Ward PA, Lepow IH, Newman LJ. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol 1968; 52: 725-36
109. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Technetium-99m labelled chemotactic peptides in acute infection and sterile inflammation. J Nucl Med 1997; 38: 1310-5
110. Rusckowski M, Qu T, Pullman J, et al. Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys. J Nucl Med 2000; 41: 363-74
111. Zhu Z, Wang Y, Zhang Y, et al. A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling. Nucl Med Biol 2001; 28: 703-8
112. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-6
113. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [18F]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32: 191-6
114. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-7
115. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62
116. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-9
117. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306
118. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A 1998; 95: 6349-54
119. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995; 92: 3113-21
120. Ogura Y, Krams SM, Martinez OM, et al. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000; 214: 795-800
121. D'Arceuil H, Rhine W, de Crespigny A, et al. 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 2000; 31: 2692-700
122. Blankenberg FG, Robbins RC, Stoot JH, et al. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest 2000; 117: 834-40
123. Hofstra L, Liem IH, Dumont AE, et al. Visualization of cell death in vivo in patients with acute myocardial infection. Lancet 2000; 356: 209-12
124. Lahorte C, Slegers G, Philippe J, et al. Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V. Biomol Eng 2001; 17: 51-3
125. Papoff G, Hausler P, Eramo A, et al. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 1999; 274: 38241-50
126. Pozzilli P, Pozzilli C, Pantano P, et al. Tracking of indium-111-oxine labelled lymphocytes in autoimmune thyroid disease. Clin Endocrinol (Oxf) 1983; 19: 111-6
127. Kaldany A, Hill T, Wentworth S, et al. Trapping of peripheral blood lymphocytes in the pancreas of patients in acute-onset insulin dependent diabetes mellitus. Diabetes 1982; 31: 463-6
128. Rubin PJ, Hartman JJ, Hasapes JP, et al. Detection of cardiac transplant rejection with 111In-labeled lymphocytes and gamma scintigraphy. Circulation 1996; 94: II298-303
129. Gallina DL, Pelletier D, Doherty P, et al. 111Indium-labelled lymphocytes do not image or label the pancreas of the BB/W rat. Diabetologia 1985; 28: 143-7
130. Signore A, Beales P, Sensi M, et al. Labelling of lymphocytes with indium-111-oxine: effect on cell surface phenotype and antibody-dependent cellular cytotoxicity. Immunol Lett 1983; 6: 151-4
131. Jaakkola K, Knuuti J, Soderlund K, et al. Labelling lymphocytes with technetium99m-hexamethyl propyleneamine oxime for scintigraphy: an improved labelling procedure. J Immunol Methods 1998; 214: 187-97
132. Jorgensen C, Couret I, Bologna C, et al. Radiolabelled lymphocyte migration in rheumatoid synovitis. Ann Rheum Dis 1995; 54: 39-44
133. Swift RI, Danpure HJ, Osman S, et al. Imaging of metastatic colorectal cancer with tumour activated killer lymphocytes. Lancet 1991; 337: 1511-2
134. Mazzoni G, Lee S, Tomer A, et al. Indium-labeled presensitised T cells for the diagnosis of graft rejection. J Surg Res 1992; 52: 85-8
135. Grimm MC, Pullman WE, Bennett GM, et al. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 1995; 10: 387-95
136. Weinberg JB, Blinder RA, Coleman RE. In vitro function of indium-111 oxine-labeled human monocytes. J Immunol Methods 1986; 95: 9-14
137. Marcus C, Thakur ML, Huynh TV, et al. Imaging rheumatic joint disease with anti-T lymphocyte antibody OKT-3. Nucl Med Commun 1994; 15: 824-30
138. Becker W, Emmrich F, Horneff G, et al. Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies. Eur J Nucl Med 1990; 17: 156-9
139. Kinne RW, Becker W, Schwab J, et al. Comparison of 99Tcm-labelled specific murine anti-CD4 monoclonal antibodies and nonspecific human immunoglobulin for imaging inflamed joints in rheumatoid arthritis. Nucl Med Commun 1993; 14: 667-75
140. Morgan DA, Ruscetti FW, Gallo RC. Selective in vitro growth factor of T lymphocytes from normal human bone marrow. Science 1976; 193: 1007-9
141. Semenzato G, Zambello R, Pizzolo G. Interleukin-2 receptor expression in health and disease. In: Waxman J, Balkwill F, editors. Interleukin-2. Oxford: Blackwell Scientific Publications, 1992; 78-105
142. Robb RJ, Greene WC, Rusk CM. Low and high affinity receptors for IL2. J Exp Mod 1984; 160: 1126-46
143. Koths K, Halenbech R. Pharmacokinetic studies on 35S-labelled recombinant interleukin-2 in mice. Cellular and molecular biology of lymphokines: International Lymphokine Workshop 1984, at Schloss Elmau, West Germany. In: Sorg C, Schimpl A, Landy M, editors. Orlando (FL): Academic Press, 1985: 779-83
144. Signore A, Parman A, Pozzilli P, et al. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123-iodine-labelled interleukin-2: an early sign of type I diabetes. Lancet 1987; II: 536-40
145. Gennuso R, Spigelman MK, Vallabhajosula S, et al. Systemic biodistribution of radioiodinated interleukin-2 in the rat. J Biol Response Mod 1989; 8: 375-84
146. Chianelli M, Signore A, Fritzberg AR, et al. The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol 1997; 24: 579-86
147. Signore A, Chianelli M, Toscano A, et al. A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2: labelling procedure and animal studies. Nucl Med Commun 1992; 13: 713-22
148. Abbs IC, Pratt JR, Dallman MJ, et al. Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123-iodine-interleukin-2. Transpl Immunol 1993; 1: 45-51
149. Signore A, Chianelli M, Annovazzi A, et al. 123I-labelled interleukin-2 scintigraphy for the in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. J Nucl Med 2000; 41: 242-9
150. Signore A, Chianelli M, Annovazzi A, et al. Imaging active lymphocytic infiltration in coeliac disease with 123I-interleukin-2 and its response to diet. Eur J Nucl Med 2000; 27: 18-24
151. Signore A, Picarelli A, Chianelli M, et al. 123I-Interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity. J Pediatr Endocrinol Metab 1996; 9: 139-44
152. Signore A, Chianelli M, Parisella MG, et al. In vivo imaging of insulitis in antoimmune diabetes. J Endocrinol Invest 1999; 22: 151-8
153. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199-204
154. Barone R, Chianelli M, Nardi G, et al. Radiolabelled interleukin-12 p40: a new radiopharmaceutical for imaging chronic TH1-mediated inflammation [abstract]. Q J Nucl Mod 1998; 42: 77
155. Rollins BJ. Monocyte chemoattractant protein-1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996; 2: 198-204
156. Kurihara T, Warr G, Loy J, et al. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997; 186: 1757-62
157. Ohtsuki K, Hayase M, Akashi K, et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001; 104: 203-8
158. Blankenberg FG, Tait JF, Blankenberg TA, et al. Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med 2001; 28: 1384-93
159. Reubi J, Mazzucchelli L, Laissue J. Intestinal vessels express a high density of somatostatin receptor in human inflammatory bowel disease. Gastroenterology 1994; 106: 951-9
160. Postema PT, Krenning EP, Wijngaarde R, et al. (111In-DTPA-D-Phe-1) octreotide scintigraphy in thyroidal and orbital Graves's disease: a parameter for disease activity? J Clin Endocrinol Metab 1994; 79: 1845-51
161. Moncayo R, Baldissera I, Decristoforo C, et al. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid 1997; 7: 21-9
162. Bohuslavizki KH, Oberwöhrmann S, Brenner W, et al. 111In-octreotide imaging in patients with long-standing Graves' ophthalmopathy. Nucl Med Commun 1995; 16: 912-6
163. Nocaudie M, Bailliez A, Itti E, et al. Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. Eur J Nucl Med 1999; 26: 511-7
164. Van Hagen P, Krenning E, Reubi J, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21: 497-502
165. Kwekkeboom DJ, Krenning EP, Kho GS, et al. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998; 25: 1284-92
166. Dunn-Dufault R, Pollak A, Thomback JR, et al. Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology. Bioconjug Chem 1999; 10: 832-7
167. Paul C, Peers SH, Woodhouse LE, et al. The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical 99mTc-RP128. J Neurosci Methods 2000; 98: 83-9
168. Caveliers V, Goodbody AE, Tran LL, et al. Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results. J Nucl Med 2001; 42: 154-61
169. Moyer BR, Vallabhajosula S, Lister-James J, et al. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection. J Nucl Med 1996; 37: 673-9
170. Shuang L, Edwards DS. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev 1999; 99: 2235-68
171. Palestro CJ, Weiland FL, Seabold JE, et al. Localizing infection with a technetium99m-labeled peptide: initial results. Nucl Med Commun 2001; 22: 695-701
172. Reubi J. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 1995; 36: 1825-35
173. Walsh DA, Mapp PI, Wharton J, et al. Localization and characterisation of substance P binding to human synovium in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 313-7
174. Mantyh CR, Vigna SR, Bollinger RR, et al. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 1995; 109: 850-60
175. Breeman W, Van Hagen M, Visser H, et al. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1] substance P. J Nucl Med 1996; 37: 108-17
176. Van Hagen PM, Breeman WA, Reubi JC, et al. Visualization of the thymus by substance P receptor scintigraphy in man. Eur J Nucl Med 1996; 23: 1508-13
177. Shaffalitzky De Muckadel OB, Aggestrup S, Stentoft P. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal men. Scand J Gastroenterol 1986; 21: 498-502
178. Diot P, Le Pape A, Nolibe D, et al. Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berilliosis: results from an experimental model. Br J Ind Med 1992; 49: 359-64
179. Perin F, Pittet JC, Hoffschir D, et al. Scintigraphic potential of J001X acylated polygalactoside for imaging inflammatory lesions in pigs. Nucl Med Biol 1993; 20: 963-71
180. Goupille P, Valat JP, Le Pape A. Imaging of synovitis in rheumatoid arthritis with radionuclide tracer. J Rheumatol 1994; 21: 1975-6
181. Goupille P, Diot P, Valat JP, et al. Imaging of pulmonary disease in rheumatoid arthritis using J001X scintigraphy: preliminary results. Eur J Nucl Med 1995;22: 1411-5
182. Diot P, Diot E, Lemarie E, et al. Imaging of pulmonary disease in scleroderma with J001X scintigraphy. Thorax 1994; 49: 504-8